The science behind the silent killer. Here is how Inimmune is developing vaccines to help solve the opioid epidemic.
Read full article:
Recent Posts
- For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set – MT High Tech Business Alliance
- Nation angler Evans helping with vital COVID research
- UM Receives Largest Single Research Award in its History
- Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital
- Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm